Under construction – not a live service
Sign in
Not yet taking people in EgyptNo phase

Compares two lymph node removal methods during keyhole surgery for right-sided colon cancer

Compares two lymph node removal extents during keyhole surgery in people with right-sided colon cancer.

Key facts

Who runs it
General Committee of Teaching Hospitals and Institutes, Egypt
Where
Alexandria, EgyptSee the site
Trial code
Registry title
D2 Versus D3 Dissection in Laparoscopic Right Hemicolectomy
Status
Not yet recruiting
People taking part
80 people, planned
Started
2 Jan 2024
Expected to end
2 Jan 2030
Type of study
Interventional, 2 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • LAPAROSCOPIC RIGHT HEMICOLECTOMY procedure (intervention)
  • Enoxaparin 40 Mg/0.4 mL Injectable Solution
  • Levofloxacin 500mg
  • LAPAROSCOPIC RIGHT HEMICOLECTOMY procedure (Conventional)
Record updated
22 September 2023

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults with cancer on the right side of the colon who will have keyhole surgery to remove it. It compares two ways of removing lymph nodes (D2 and D3).

Sex
All sexes can join.
Disease stage
Cancer of the right side of the colon (caecum, ascending colon or hepatic flexure), confirmed by CT entero-colonography, colonoscopy and biopsy. No spread to other organs.

Main reasons for not taking part

  • Emergency surgery (blockage, or a hole in the bowel with peritonitis spread through the belly)
  • Cancer that has spread to other organs (metastatic)
  • ASA score of IV or higher
  • Need for more than one surgical procedure
  • Switch to open surgery

The registry criteria, word for word

Show all 9 criteriaShow less

Who can take part

  • Patients with right-side colon cancer (caecum, ascending, or hepatic flexure)
  • Diagnosed by CT entero-colonography
  • Diagnosed by colonoscopy
  • Diagnosed by biopsy

Who cannot take part

  • Need for more than one surgical procedure
  • Conversion to open surgery
  • Emergency surgery (obstruction, perforation with generalized peritonitis),
  • Metastatic tumor diagnosed
  • ASA score of IV or higher

Where in Egypt

  • The surgical department of Medical Research Institute Hospital, Alexandria UniversityAlexandria, EgyptContact: M. H. Ashour, MDNo longer taking part

About the trial

What the trial wants to find out

Evaluating the differences between D2 and D3 lymphadenectomy in laparoscopic right hemicolectomy in patients with right cancer colon post-operative outcome, intra-operative blood transfusion, post-operative ICU admission, anastomotic leakage, lymph node harvesting in the final specimen, and six months follow up and overall survival time after 5-years

The 2 groups in the trial

  • Laparoscopic hemicolectomy with Complete Mesocolic ExcisionExisting treatment, for comparison

    Patients will have laparoscopic hemicolectomy with Complete Mesocolic Excision, D3 lymph node dissection.

    Treatment: LAPAROSCOPIC RIGHT HEMICOLECTOMY procedure (intervention), Enoxaparin 40 Mg/0.4 mL Injectable Solution, and Levofloxacin 500mg

  • Conventional laparoscopic right hemicolectomyExisting treatment, for comparison

    Patients will have conventional laparoscopic right hemicolectomy with D2 lymph node dissection.

    Treatment: Enoxaparin 40 Mg/0.4 mL Injectable Solution, Levofloxacin 500mg, and LAPAROSCOPIC RIGHT HEMICOLECTOMY procedure (Conventional)

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Official title
D2 Versus D3 Dissection in Laparoscopic Right Hemicolectomy In Right Cancer Colon Patients: A Randomized Controlled Trial
Plain-language title
Compares two lymph node removal methods during keyhole surgery for right-sided colon cancerGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 12 November 2026.
Record updated
22 September 2023